ABBV Aug 2024 180.000 call
| Previous close | 0.9700 |
| Open | 1.0500 |
| Bid | 0.8500 |
| Ask | 0.9100 |
| Strike | 180.00 |
| Expiry date | 2024-08-16 |
| Day's range | 0.9700 - 1.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.33k |
ZacksInvestors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Insider Monkey12 Undervalued Stocks That Just Raised Their Dividends
In this article, we discuss 12 best dividend stocks that are undervalued and have just raised their payouts. You can skip our detailed analysis of dividend and value stocks and their previous performance, and go directly to read 5 Undervalued Stocks That Just Raised Their Dividends. Dividend stocks didn’t perform well in 2023. However, this […]
PR NewswireAbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
AbbVie (NYSE: ABBV) and Gilgamesh Pharmaceuticals today announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in psychiatry and Gilgamesh's innovative research platform to discover novel neuroplastogens.
